Clinical Trial Update: A Study of Mosliciguat in PH-ILD [Phase 2]

View source ↗

Summary

Phase 2 study evaluating mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease; current status is active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Pulmonary Hypertension

Drugs mentioned

• Mosliciguat (mosliciguat)

Snippet

Sponsor: Pulmovant, Inc. | Conditions: Pulmonary Hypertension, Interstitial Lung Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING